Clioquinol

This classification denotes an anti-infective agent with the molecular formula C9H5ClINO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7BHQ856EJ5, chemically known as 8-quinolinol, 5-chloro-7-iodo- but generally known as clioquinol, which bears US NIH Compound Identifier 2788. European Medicines Agency schedules Clioquinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06669MIG. The term CLIOQUINOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules clioquinol in its Anatomical Therapeutic Chemical (ATC) Classification. CLIOQUINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clioquinol under HS 29334990 and SITC 51575. As of Q4 2014, CLIOQUINOL remains the US FDA Preferred Term for this commodity. Clioquinol bears US NLM identifiers UMLS ID C0021978 and NCI Concept Code C65337. SMILES: IC1C(O)C2NCCCC2C(CL)C1.